Skip to main content

Table 3 Shift from baseline in hyperemia severity grading at follow-up

From: Bimatoprost 0.01% in treatment-naïve patients with open-angle glaucoma or ocular hypertension: an observational study in the Korean clinical setting

Baseline

Week 6, n (%)

None

Trace

Mild

Moderate

Severe

0 (none)

34 (13.5)

5 (2.0)

0 (0)

0 (0)

0 (0)

+0.5 (trace)

26 (10.4)

41 (16.3)

8 (3.2)

1 (0.4)

0 (0)

+1 (mild)

21 (8.4)

49 (19.5)

26 (10.4)

1 (0.4)

0 (0)

+2 (moderate)

11 (4.4)

7 (2.8)

7 (2.8)

7 (2.8)

0 (0)

+3 (severe)

2 (0.8)

2 (0.8)

2 (0.8)

0 (0)

1 (0.4)

Missing

13

22

8

1

0

Baseline

Week 12, n (%)

0 (none)

33 (15.0)

6 (2.7)

1 (0.5)

0 (0)

0 (0)

+0.5 (trace)

20 (9.1)

38 (17.3)

13 (5.9)

0 (0)

0 (0)

+1 (mild)

22 (10.0)

35 (15.9)

15 (6.8)

1 (0.5)

0 (0)

+2 (moderate)

6 (2.7)

11 (5.0)

7 (3.2)

7 (3.2)

0 (0)

+3 (severe)

0 (0)

3 (1.4)

1 (0.5)

0 (0)

1 (0.5)

Missing

26

33

14

2

0